A detailed history of Cardinal Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cardinal Capital Management holds 73,035 shares of MRK stock, worth $9.33 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
73,035
Previous 68,903 6.0%
Holding current value
$9.33 Million
Previous $7.51 Million 28.29%
% of portfolio
1.58%
Previous 1.43%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$113.24 - $131.95 $467,907 - $545,217
4,132 Added 6.0%
73,035 $9.64 Million
Q4 2023

Jan 26, 2024

BUY
$100.18 - $109.02 $15,527 - $16,898
155 Added 0.23%
68,903 $7.51 Million
Q3 2023

Oct 16, 2023

BUY
$102.95 - $114.33 $55,593 - $61,738
540 Added 0.79%
68,748 $7.08 Million
Q2 2023

Jul 12, 2023

BUY
$108.61 - $118.38 $6,733 - $7,339
62 Added 0.09%
68,208 $7.87 Million
Q1 2023

Apr 18, 2023

SELL
$102.94 - $114.86 $61,764 - $68,916
-600 Reduced 0.87%
68,146 $7.25 Million
Q4 2022

Jan 20, 2023

SELL
$87.44 - $112.11 $77,734 - $99,665
-889 Reduced 1.28%
68,746 $0
Q3 2022

Oct 21, 2022

BUY
$84.53 - $94.96 $41,250 - $46,340
488 Added 0.71%
69,635 $6 Million
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $39,490 - $44,764
473 Added 0.69%
69,147 $6.3 Million
Q1 2022

Apr 21, 2022

BUY
$73.51 - $82.4 $184,436 - $206,741
2,509 Added 3.79%
68,674 $5.64 Million
Q4 2021

Jan 18, 2022

SELL
$72.28 - $90.54 $5,493 - $6,881
-76 Reduced 0.11%
66,165 $5.07 Million
Q3 2021

Oct 21, 2021

SELL
$71.68 - $78.83 $49,530 - $54,471
-691 Reduced 1.03%
66,241 $4.98 Million
Q2 2021

Jul 14, 2021

BUY
$70.31 - $77.77 $110,667 - $122,409
1,574 Added 2.41%
66,932 $5.21 Million
Q1 2021

Apr 19, 2021

BUY
$68.86 - $81.11 $186,128 - $219,240
2,703 Added 4.31%
65,358 $5.04 Million
Q4 2020

Feb 01, 2021

BUY
$71.77 - $79.65 $98,181 - $108,961
1,368 Added 2.23%
62,655 $5.13 Million
Q3 2020

Oct 16, 2020

BUY
$73.18 - $82.95 $31,613 - $35,834
432 Added 0.71%
61,287 $5.08 Million
Q2 2020

Jul 16, 2020

BUY
$70.42 - $80.13 $5,492 - $6,250
78 Added 0.13%
60,855 $4.71 Million
Q1 2020

Apr 20, 2020

SELL
$63.36 - $87.82 $119,053 - $165,013
-1,879 Reduced 3.0%
60,777 $4.68 Million
Q4 2019

Jan 21, 2020

SELL
$77.58 - $87.54 $96,819 - $109,249
-1,248 Reduced 1.95%
62,656 $5.7 Million
Q3 2019

Oct 18, 2019

SELL
$76.08 - $82.93 $32,181 - $35,079
-423 Reduced 0.66%
63,904 $5.38 Million
Q2 2019

Jul 08, 2019

SELL
$69.84 - $81.59 $19,275 - $22,518
-276 Reduced 0.43%
64,327 $5.39 Million
Q1 2019

Apr 11, 2019

SELL
$69.58 - $79.36 $33,050 - $37,696
-475 Reduced 0.73%
64,603 $5.37 Million
Q4 2018

Jan 15, 2019

BUY
$65.24 - $75.71 $37,839 - $43,911
580 Added 0.9%
65,078 $4.97 Million
Q3 2018

Oct 25, 2018

SELL
$57.69 - $67.84 $32,940 - $38,736
-571 Reduced 0.88%
64,498 $4.58 Million
Q2 2018

Jul 25, 2018

SELL
$50.83 - $59.72 $1,626 - $1,911
-32 Reduced 0.05%
65,069 $3.95 Million
Q1 2018

Apr 25, 2018

SELL
$50.96 - $59.23 $63,037 - $73,267
-1,237 Reduced 1.86%
65,101 $3.55 Million
Q4 2017

Feb 01, 2018

BUY
$51.62 - $61.64 $65,247 - $77,912
1,264 Added 1.94%
66,338 $3.73 Million
Q3 2017

Oct 24, 2017

BUY
$58.67 - $63.13 $3.82 Million - $4.11 Million
65,074
65,074 $4.17 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.